Open access peer-reviewed chapter

Genetic Variability of Entamoeba histolytica Strains

Written By

Shler Akram Faqe Mahmood

Submitted: 03 July 2022 Reviewed: 28 July 2022 Published: 19 January 2023

DOI: 10.5772/intechopen.106828

From the Edited Volume

Genetic Diversity - Recent Advances and Applications

Edited by Mahmut Çalişkan and Sevcan Aydin

Chapter metrics overview

79 Chapter Downloads

View Full Metrics

Abstract

Entamoeba histolytica is pathogenic parasite that causes asymptomatic infection mostly; however, it may also cause invasive intestinal amoebiasis and liver abscess, leading to significant rates of human mortality globally. The clinical outcome of the infection with the parasite is variable and evidence suggested the contribution of genetic diversity within E. histolytica to human disease. The information documented the whole-genome sequence of the E. histolytica reference laboratory strain (HM-1:IMSS) and the development of sophisticated molecular technique potentiate ability to identify strains of E. histolytica that may lead to insights into the population structure, virulence, pathogenesis, clinical outcome of the disease and epidemiology of the organism.

Keywords

  • Entamoeba histolytica strains
  • genetic diversity
  • inter-species variability
  • E. histolytica genetic biomarker

1. Introduction

Entamoeba histolytica is a pseudopod-forming protozoan parasite that inhabit primarily in human gastrointestinal tract. Amoebiasis can be asymptomatic in the majority (about 90%) of infected people or can lead to severe invasive infection characterized by symptoms such as bloody diarrhoea, abdominal pain, flatulence, nausea, and vomiting. In some cases, amoebae extend out of intestinal tract forming ulceration and abscess, particularly in liver causing amoebic liver abscesses [1]. E. histolytica affects 50 million individuals annually [2], causing about 11,300 fatality throughout the world, making it the fourth leading cause of death due to parasitic infections [3]. Amoebiasis is mainly transmitted by faecal-oral ingestion of contaminated water or food with cystic stage and hence distributed more in developing countries [4]. The parasite life cycle is simple, converting between two stages: a cyst stage that survives in adverse environmental conditions, transmitting the disease and a trophozoite (the vegetative form), which invades the host epithelial cells causing diseases [5]. Infection begins by excystation of the cyst, cyst cell membranes are disintegrated by the effect of the gastric juice and bile salts yielded motile trophozoites in the small bowel and then followed by adherence and invasions of trophozoites to colonic mucins and colonic epithelial cells. At the lower part of the ileum, the trophozoites encysted and released from intestinal mucosa and excreted with faeces to contaminate the environment repeating the cycle again. In some cases, the trophozoites disseminate haematogenously resisting the complement proteins and appear to have special preference for hepatic tissue [6]. The molecular pathway that the parasite followed during the processes of tissue invasion is poorly understood.

The differences reported in the clinical outcome of the infections with E. histolytica, which ranged from asymptomatic carriers to invasive amoebiasis and even to extra-intestinal abscess formation, may be due to genetic variability and inter-strain-related virulence genes in the genomic sequence of E. histolytica [7].

It has been suggested that the presence of these genetic alterations could have either permitted the parasite to more readily evade host immune responses or be related to higher virulence, causing more severe clinical presentations [8].

Advertisement

2. Epidemiology of amoebiasis

E. histolytica has been reported worldwide, with the higher prevalence rates in tropical and subtropical of underdeveloped regions where hygiene and sanitation conditions are compromised [9, 10]. Amoebic endemicity has been recorded in Africa, Mexico, Central and South America, Pacific islands, and Asia, where the major way for transmission is feco-oral. Even the expression of clinical features of amoebiasis which range from asymptomatic infections, acute dysentery and chronic-disseminated infection are varied geographically. For example, amoebic dysentery is predominate in Egypt [11], whereas amoebic liver abscess is more prevalent in both South Africa and Hue City in Vietnam [12]. In developed countries, low incidence rats are reported; and most E. histolytica infections are sexually acquired among homosexual community, for example, those documented in Australia, Europe, North America and parts of Asia [2, 10, 13, 14]. In the United States, the incidence of amoebic infections is quite low, yet amoebiasis-related deaths still usually occur, responsible for at least five deaths per year [15]. Most reported cases of amoebiasis in the United States are seen in immigrants or returning travellers from endemic countries [16]. Data from the international surveillance and monitoring system (GeoSentinel Surveillance Network) have documented that E. histolytica is the third most common pathogen isolated from returning travellers with infectious intestinal disease [16]. Travellers to the Middle East, South Asia, and South America appear to have the highest risk of amoebiasis.

Evaluating the global burden of E. histolytica infection is quite difficult due to limitation in diagnostic capacity and surveillance in most regions endemic with the parasite. Epidemiological studies can be affected by several factors, for example, study design, geographic area, sample size, symptom severity, incubation and the sensitivity of the diagnostic tool used. However, seroprevalence reports of E. histolytica in rural areas of Mexico showed as high as 42% [17]. Infant during their first year of life of Dhaka, Bangladesh, reported amoebic diarrhoea in 11% of the children [18]. Prevalence of E. histolytica based on PCR detection revealed that the infection rate was 13.7% in northeast states of India and 6% in Northern Iraq [19, 20]. Seropositive results for E. histolytica were accounted for 11% of seven provinces of China and 41% among male homosexual community in the provinces of Beijing and Tianjin [21, 22]. Depending on the antigen detection of E. histolytica from stool samples, the parasite reported the highest rate among the enteropathogens that related to the diarrhoea presented by 20% among children under the age of 16 years of Jeddah, Saudi Arabia [23]. Despite widespread occurrence of amoebiasis in Africa, limited information is present about the infection rates and epidemiology of E. histolytica. However, a cross-sectional study in South Africa showed that the prevalence of E. histolytica was 8.5% of patients attending gastroenterology clinics detected by PCR [24]. E. histolytica is represented as the one of the top 10 causative agents of diarrhoea in children under the age of 5 years in regions of sub-Saharan Africa and South Asia, according to the large Global Enteric Multi-Center Study (GEMS) [25].

The global impact of amoebic infection and amoebiasis remains significant, nevertheless challenging to quantify with accuracy given several epidemiologic and methodologic difficulties, but prevalence rates persist as high as 40% in certain populations.

Advertisement

3. Whole-genome sequences of Entamoeba

The genome assembly of E. histolytica (strain HM1:IMSS) contains 20,800,560 base pairs of DNA in 1496 scaffolds; about 75% of the genome are AT-rich regions and since there are 8333 annotated genes, therefore the coding sequence accounts for nearly 50% of all assembled sequences [26].

The genome shows impressive evolutionary features, in particular, the presence of substantial number of genes (at least 68) that seems to have been acquired by horizontal gene transfer from bacteria. Most of these transferred genes appear to have been ancient and implicated in metabolic processes specific for the anaerobic lifestyle of the organisms [27].

Genomic structure and architecture of Entamoeba are still not well characterized. For example, it is unknown whether there is a natural ploidy or haploid number of chromosome, although both are estimated [28]. The processes of genetic reassortment are common in E. histolytica, which are important to determine parasite population dynamics and parasite phenotypes through detecting factors that can trigger this genetic reassortment. Therefore, it is possible due to high levels of recombination to generate strains of E. histolytica with increased virulence expressing transient polygenic traits as results of association of different alleles. In spite of exhibiting of asexual reproduction by E. histolytica trophozoite, structural diversity exist in this species due to the union that could happen between different trophozoite strains co-infected the same host [7].

There are complex patterns of E. histolytica molecular karyotype, which display differences in chromosome sizes between strains and a mixture of circular and linear DNA [28, 29]. Circular DNA structures are present in E. histolytica, for instance, rRNA gene found in multiple copies per nucleus; these segmental duplications in the genomic DNA might be represented by the circular molecules of DNA [29, 30, 31]. However, it is unknown whether the copies of these DNA structures are present in different number from that of the ‘core’ chromosomes and if they segregate in the same way or not. Furthermore, the exhibition of short tandem repeats in the tRNA genes represented an unusual organization of E. histolytica genome, which appears in arrays of tandem duplicated combinations of genes separated by DNA [32]. The tRNA gene arrangement seems to be quite variable and has altered in the evolution of different species linages; therefore, it is used as population genetic markers to show different isolates of E. histolytica (and E. dispar) [33].

Advertisement

4. Study strain variation of E. histolytica

4.1 Isoenzymes or zymodeme analysis

The first observation of the variation within E. histolytica came from isoenzyme studies by Sargeaunt and his collegues (1978) [34]. These studies not only discriminate the ‘non-pathogenic’ and ‘pathogenic’ E. dispar and E. histolytica, respectively, but also identified variations within each group. A zymodeme can be described as a group of amoeba variants or strains that sharing the same electrophoretic pattern for several enzymes. Zymodemes consist of electrophoretic patterns of malic enzyme, glucose phosphate isomerase, hexokinase and phosphoglucomutase isoenzyme [35]. Since then, a total of 24 different zymodemes have been identified, 21 of which are from human isolates (9 of E. histolytica and 12 of E. dispar) [35]. However, the presence of starch in the medium influences the patterns of most variable zymodeme and upon removal of bacterial floras from the medium many zymodemes disappear, suggesting that at least some of the bands are of bacterial rather than amoebic origin [36, 37]. Accordingly, only four different stable isoenzyme patterns remains, three for E. histolytica (II, XIV, and XIX) and one for E. dispar (I) [36]. Isoenzyme (zymodeme) analysis was the classical gold standard method to differentiate E. histolytica subgroups prior to the development of DNA-based techniques. Zymodeme or isoenzyme analysis has a number of drawbacks, such as the difficulty of performing the test and targeting only a limited diversity of strains. It is a time-consuming technique; it depends on the growing of amoebae in culture and requires harvesting a large number of cells for the enzyme analysis. Cultivation of amoebae is not always successful; it may result in selection bias, and consequently, one species or strain may outgrow the other, which is not preferable when studying zymodemes. Zymodeme analysis is not easily incorporated into routine clinical laboratory work because of the expertise required to culture the parasites, the complexity of the diagnostic process and the cost. Isoenzyme analysis has been replaced by DNA-based methods as the method of choice for studying Entamoeba species [38].

4.2 PCR-restriction fragment length polymorphism

Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis is molecular-based technique to differentiate species within the genus or to show the genetic diversity of certain species or strain. The method involves the digestion of PCR products of specific gene with restriction enzymes to produce fragments of different numbers and sizes based upon the differences in the number and location of restriction sites present in the amplicon. The selections of the target genes and restriction enzymes are based on the way that, for instance, different species of certain genus produce the same-size amplicon but show different banding size or patterns for different species by gel electrophoresis after been digested with specific restriction enzyme [39].

Molecular typing based on polymorphic genetic loci has been confirmed to aid in precise examination and identification of population structures of E. histolytica isolates in nature [40]. However, the differences in the clinical outcome of the E. histolytica infections may be due to genetic variability and inter-strain-related virulence present in the genomic sequence of E. histolytica [41].

4.3 Serine-rich E. histolytica protein (SREHP)

The majority of the biological functions are initiated through proteins, identifying certain proteins and estimating their functions enabling their potential use as markers for studying population nature and genetic diversity. The highest immunogenic protein among all identified proteins in Entamoeba species is SREHP, which is an extracellular protein with a surface antigen exposed for host immune system [42]. SREHP plays a vital role in the parasite virulence through several mechanisms, such as participation in signalling pathway via possessing signal peptide; participation in the process of phosphorylation and protein modification; having peptidase activity and representing as potent chemoattractant for trophozoites [43]. The presence of multiple tandem-repeat sequences in the central region of SREHP genes can be used to study inter-strain variation and genetic polymorphism in E. histolytica [44].

Furthermore, SREHP is critical in phagocytosis and immune evasion. As it also plays a role in adherence to apoptotic cells, it influences the virulence of the parasite [43]. Furthermore, SREHP’s polymorphism—the variable numbers of tandem repeats—might mediate a wider adherence range or variable affinity, suggesting that the tandem repeats are binding domains. Thus, this polymorphism plays a vital role in the pathogenicity of different E. histolytica strains [43, 45, 46]. The presence of polymorphisms in SREHP between homologous loci on allelic chromosomes could also be due to either the presence of more than one strain of E. histolytica in a single sample or the presence of repeated loci at several locations in the genome, each resulting in a different PCR product [28]. The presence of a high level of genetic diversity may reflect the existence of several different clones in a limited geographic area and/or rapid production of SREHP repeats. Evidence has suggested that diversity among E. histolytica strains based on gene polymorphism may result from new haplotype creation due to the shuffling of alleles during genetic recombination and reassortment [47]. Notably, the presence of sexual reproduction in the natural population of E. histolytica has been suggested based on the discovery of complement genes that are necessary for meiosis in the E. histolytica genome. Sexual reproduction is enormously important in gene exchange (e.g., in drug resistance and virulence genes) and consequently generates genotypes that spread rapidly. This may also identify the linkage disequilibrium patterns among genetic markers as that of SREHP gene polymorphism [26].

4.4 Short tandem repeats (STRs)

The tRNA genes of E. histolytica are highly polymorphic that present in clusters of one to five distinct types, interposed with non-coding short tandem repeats (STRs) and these clusters are in turn repeated to form long arrays. The arrays make up about 13%of the genome. Since the STR regions displayed a high degree of intra-specific variation regarding type, repeat number and the arrangement patterns between tRNA array units, therefore these features make STR very useful genetic tool for quantification of Entamoeba evolutionary divergence and assessing virulence of individual E. histolytica strains [48].

A number of primers lying in the non-coding regions were used for the identification of E. histolytica strain based on tRNA-associated STRs. Later, primers are designed to enable concurrent differentiation and strain typing of E. histolytica and E. dispar [49]. These markers have shown to be stable and suitable for tracking the transmission of a known strain within an individual, family unit, and/or community [50]. Moreover, it has been documented that the same strain of E. histolytica was never identified in epidemiologically unlinked patients, which reflects a remarkable degree of genetic diversity within this relatively limited geographic area. In certain endemic regions with E. histolytica and E. dispar, the utilization of species-specific primers is of great importance because a significant number of individuals could be infected with both species.

4.5 Chitinase

The repeat-containing region of Chitinase gene of E. histolytica is least polymorphic as compared with tRNA-linked loci and SREHP; therefore, this gene is less commonly used for strain differentiation and studying genetic diversity [46]. Chitinase gene repeats ranged from 84 to 252 nucleotides consistent with four heptapeptide repeats (28 amino acids) to 12 heptapeptide repeats (84 amino acids). Studies have revealed that the nucleotide of chitinase gene repeat of certain isolate was identical to that of the standard strain, suggesting that the similarity could be due to chance convergence rather than a common ancestor [51].

4.6 Use of retrotransposons as genetic markers

4.6.1 Transposon display

The genomic sequence of E. histolytica displays abundant non-LTR (long terminal repeats) retrotransposons that are dispersed uniformly throughout the genome. In Entamoeba, the term long interspersed elements (EhLINEs) is used to describe the autonomous non-long terminal repeat retrotransposons (LTR) elements, while short interspersed elements (EhSINEs) referred to short non-autonomous elements. Several families of EhLINEs and EhSINEs have been detected in E. histolytica [28, 52, 53]. It has been documented that both EhLINEs/EhSINEs account for approximately 6% of the Entamoeba genome. Moreover, EhLINEs and EhSINEs are present on all chromosomes and estimated to have 140 copies of these elements per genome, which appear to be in non-telomeric position [54]. It has been suggested that EhLINEs and EhSINEs were inserted at different genomic location during the course of evolution in various strains; therefore, they can be utilized as genetic markers for strain identification of E. histolytica [55].

Amplified fragment length polymorphism (AFLP) is a highly sensitive technique for detecting polymorphisms in DNA, the method based on restriction enzymes that cut the DNA and adaptors attached to the ends of the fragments. The DNA fragments are then amplified using PCR, and their varying lengths can then be visualized on gel after been electrophoresed. Transposon display (TD) is a modified AFLP technique uses specific primer that anchors in a transposon to simultaneously identify up to several hundred markers in the genome [56, 57]. TD consists of amplification of sequences flanking the transposon by ligation-mediated PCR. The resulting fragments are locus-specific and can be analysed by polyacrylamide gel electrophoresis. Transposon display has been used to investigate and explore the behaviour and stability of transposable elements in plants [58]. The technique has also been effectively used to display yeast mutants conferring quantitative phenotypes [59].

Laboratory strains of E. histolytica grown axenically showed different patterns of TD when primers targeted various regions of EhSINE1 [60]. TD technique has many potential advantages over other methods. The technique is being developed to study DNA isolated directly from both ALA pus and faecal samples. Furthermore, more than one polymorphic band is yielded by TD as compared with single-band polymorphism in a normal PCR. It is low-cost technique since the method based on only one reaction through single-specific primer with capacity to display a whole range of bands in each strain. The use of transposon-specific primer makes it more sensitive and reliable than AFLP. Thus, this technique could be utilized in performing significant epidemiological studies and large-scale molecular typing of this parasite. Intensive analysis and studying of the bands may help in understanding the dynamics of EhSINE retrotransposition in various strains of E. histolytica.

4.6.2 REP PCR

The repetitive element palindromic-polymerase chain reaction (REP PCR) was first devised for strain and serotype identification in enteric bacteria [61]. REP PCR is commonly used in clinical laboratories for detecting strains of bacteria, fungal and dermatophytes [62]. The method depends on the targeting of interspersed repetitive consensus sequences in the genome that enables amplification of diverse-sized DNA fragments and may be present in both the orientations on the chromosome.

The designed PCR primers must target ‘read outward’ from the repeats, amplifying the region between two such elements in either direction. These primers are complementary and attached to dispersed repeated sequences. This may result in varying band patterns when the repetitive sequences are located in different positions in the genome of different strains. This principle was employed successfully using EhLINEs/EhSINEs dispersed in the E. histolytica genome. For this purpose, several sets of primers were designed from EhLINEs and EhSINEs to involve the entire stretch of each element. Each specific strain generated a unique profile of REP PCR fingerprint consisting of multiple bands of different sizes [63]. This could be used to establish relationships between different strains. This procedure can provide extended variation between the strains than the tandem repeat technique since using this, many loci can be investigated simultaneously.

4.7 Single-nucleotide polymorphism

Single-nucleotide polymorphism (SNPs) is the simplest form of variation in the genomic DNA sequence on bases of single nucleotide. To investigate the genetic diversity of E. histolytica strains, 9077 bp have been sequenced from 14 isolates [64]. It was proposed that coding and non-coding regions are challenged to several selection pressures and could be related to specific clinical outcome of the disease. A statistically significant difference was recorded in the presence of SNPs with higher rates in non-coding regions as compared with coding regions. The SNP markers are of great importance in studying of evolutionary analyses because these markers are evolutionarily stable and unlikely to mutate. Nevertheless, regarding Entamoeba, this method is still in the early stages and needs to be further explored. The procedure also requires large-scale sequencing of the PCR products.

4.8 Microarray

Microarray is a genomic tool used to detect the expression of thousands of genes simultaneously from a sample. Microarray assay has been used successfully for the identification of Entamoeba and other water-borne protozoa [65]. Genotyping of E. histolytica based on microarray assay can be useful for the study of genetic diversity and potential genotypic-phenotypic relations of the clinical isolates. The technique involves powerful DNA amplification that combines with subsequent hybridization to oligonucleotide probes specific for several target sequences. The distinct importance of this detection method is that it can investigate thousands of genes all together at once. In addition to the study of the of inter-strain variability, many biological properties of genes can be revealed through microarray technique, such as, detection of genes regulated by drug exposure, tissue invasion and developmental changes. For studying genetic diversity, sequenced genomic DNA (gDNA) clones of E. histolytica (HM-1:IMSS) were used to generate an 11,328 clone genomic DNA microarray; all clones on the array are beneficial for analysis since the genetic differences in coding and non-coding regions are equally important in determining the genotype of a strain [66].

Besides conserved genes, like rRNA and hsp, which have been extensively used as diagnostic markers, several genus- and species-specific genes such as the cysteine protease gene (cp1) were selected as amplification targets to avoid possible cross-hybridization and co-amplification issues.

The DNA microarray assay has been used in large-scale expression profiling of Entamoeba species/strains, which permits the study of genetic and expression differences that may associate with parasite virulence. However, more studies are needed to confirm the significance of these genes in amoebic virulence and pathogenesis. The main restrictions of the technique for diagnostic uses are the cost-intensive, its robustness and labour inputs [66].

Advertisement

5. Conclusions

Several powerful molecular techniques and genetic biomarker are available nowadays, such as chitinase, SREHP polymorphisms, SNPs, STRs, retrotransposons and microarray all provide informative understanding to study parasite biology. For examples, studying STR regions in tRNA genes of E. histolytica revealed inter-species variation that may related to the clinical outcome of the disease and may provide evidence for the geographic origin of the infection [67]. Moreover, studies documented the presence of high genetic diversity among E. histolytica strains using PCR-RFLP analysis on SREHP gene and addressed the association of the strains with the clinical presentation of the disease [8, 44, 68]. The investigations based on chitinase gene sequence repeat suggested the existence of strains of E. histolytica that could be non-pathogenic, invasive for the intestinal mucosa or invasive for liver tissue [46, 69, 70]. Another genetic marker, TD technique was developed to identify strains of E. histolytica using retrotransposon EhSINE1, and it showed to be cost effective, sensitive and reliable procedure that successfully characterizes the strains based on geographical distribution [60]. A polymorphism study showed 14 genotypic patterns among the 14 isolates of E. histolytica using SNPs and recorded extensive diversity between coding and non-coding regions [64]. Microarray analysis was applied to distinguishing the symptomatic and asymptomatic strains of E. histolytica through investigating the gene expression profile of both virulent strain (HM1-IMSS) and non-virulent strain (Rahman) [71]. The study inspecting a total of 54 hybridizations and statistical analysis was performed for each gene; the most common differentially regulated genes were in carbohydrate metabolism, virulence-related functions (CPs, Gal/GalNAc lectin), signal transduction pathways, antibacterial activity (AIG1) and transcription factors [71]. Consequently, all these tools and biomarkers can aid in determining the role of E. histolytica genetics in the outcome of infection and can be used for population-based studies as well as to develop an improved evolutionary and phylogenetic framework for the parasite.

References

  1. 1. Kantor M, Abrantes A, Estevez A, Schiller A, Torrent J, Gascon J, et al. Entamoeba histolytica: Updates in clinical manifestation, pathogenesis, and vaccine development. Canadian Journal of Gastroenterology and Hepatology. 2018;2018:4601420. DOI: 10.1155/2018/4601420
  2. 2. World Health Organization. Pan American health organization. UNESCO report of a consultation of experts on amoebiasis. Weekly Epidemiological Record. 1997;72:97-99
  3. 3. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388:1459-1544
  4. 4. Shirley D-AT, Watanabe K, Moonah S. Significance of amebiasis: 10 reasons why neglecting amebiasis might come back to bite us in the gut. PLOS Neglected Tropical Diseases. 2019;13:e0007744. DOI: 10.1371/journal.pntd.0007744
  5. 5. Carrero JC, Reyes-López M, Serrano-Luna J, Shibayama M, Unzueta J, León-Sicairos N, et al. Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. International Journal of Medical Microbiology. 2020;310:151358. DOI: 10.1016/j.ijmm.2019.151358
  6. 6. Tharmaratnam T, Kumanan T, Iskandar MA, D’Urzo K, Gopee-Ramanan P, Loganathan M, et al. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: A public health problem. Tropical Medicine and Health. 2020;48:2. DOI: 10.1186/s41182-020-0193-2
  7. 7. Gilchrist CA. The E. histolytica genome structure and virulence. Current Tropical Medicine Reports. 2016;3:158-163. DOI: 10.1007/s40475-016-0088-9
  8. 8. Mahmood SAF, Mustafa BH. Genetic variability of E. histolytica strains based on the polymorphism of the SREHP gene using nested PCR-RFLP in Erbil, North Iraq. Cellular and Molecular Biology. 2020;66:82-87. DOI: 10.14715/cmb/2019.66.1.14
  9. 9. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2095-2128. DOI: 10.1016/S0140-6736(12)61728-0
  10. 10. Ximénez C, Morán P, Rojas L, Valadez A, Gómez A. Reassessment of the epidemiology of amebiasis: State of the art. Infection, Genetics and Evolution. 2009;9:1023-1032. DOI: 10.1016/j.meegid.2009.06.008
  11. 11. Abd-Alla MD, Ravdin JI. Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt. Tropical Medicine & International Health. 2002;7:365-370. DOI: 10.1046/j.1365-3156.2002.00862.x
  12. 12. Blessmann J, Van Linh P, Nu PA, Thi HD, Muller-Myhsok B, Buss H, et al. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in Central Vietnam. The American Journal of Tropical Medicine and Hygiene. 2002;66:578-583. DOI: 10.4269/ajtmh.2002.66.578
  13. 13. Ali IK, Clark CG, Petri WA Jr. Molecular epidemiology of amebiasis. Infection, Genetics and Evolution. 2008;8:698-707. DOI: 10.1016/j.meegid.2008.05.004
  14. 14. Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who have sex with men. The Lancet Infectious Diseases. 2012;12:729-736. DOI: 10.1016/s1473-3099(12)70147-0
  15. 15. Gunther J, Shafir S, Bristow B, Sorvillo F. Short report: Amebiasis-related mortality among United States residents, 1990-2007. The American Journal of Tropical Medicine and Hygiene. 2011;85:1038-1040. DOI: 10.4269/ajtmh.2011.11-0288
  16. 16. Swaminathan A, Torresi J, Schlagenhauf P, Thursky K, Wilder-Smith A, Connor BA, et al. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. The Journal of Infection. 2009;59:19-27. DOI: 10.1016/j.jinf.2009.05.008
  17. 17. Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF. Seroepidemiology of Entamoeba histolytica infection in general population in Rural Durango, Mexico. Journal of Clinical Medical Research. 2015;7:435-439. DOI: 10.14740/jocmr2131w
  18. 18. Mondal D, Minak J, Alam M, Liu Y, Dai J, Korpe P, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clinical Infectious Diseases. 2012;54:185-192. DOI: 10.1093/cid/cir807
  19. 19. Nath J, Ghosh SK, Singha B, Paul J. Molecular epidemiology of Amoebiasis: A cross-sectional study among north east Indian population. PLoS Neglected Tropical Diseases. 2015;9:e0004225. DOI: 10.1371/journal.pntd.0004225
  20. 20. Mahmood S, Mustafa H. Molecular identification and prevalence of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in Erbil City, Northern Iraq. Polish Journal of Microbiology. 2020;69:1-10. DOI: 10.33073/pjm-2020-028
  21. 21. Yang B, Chen Y, Wu L, Xu L, Tachibana H, Cheng X. Seroprevalence of Entamoeba histolytica infection in China. The American Journal of Tropical Medicine and Hygiene. 2012;87:97-103. DOI: 10.4269/ajtmh.2012.11-0626
  22. 22. Zhou F, Li M, Li X, Yang Y, Gao C, Jin Q , et al. Seroprevalence of Entamoeba histolytica infection among Chinese men who have sex with men. PLOS Neglected Tropical Diseases. 2013;7:e2232. DOI: 10.1371/journal.pntd.0002232
  23. 23. Hegazi MA, Patel TA, El-Deek BS. Prevalence and characters of Entamoeba histolytica infection in Saudi infants and children admitted with diarrhea at 2 main hospitals at South Jeddah: A re-emerging serious infection with unusual presentation. The Brazilian Journal of Infectious Diseases. 2013;17:32-40. DOI: 10.1016/j.bjid.2012.08.021
  24. 24. Ngobeni R, Samie A, Moonah S, Watanabe K, Petri WA Jr, Gilchrist C. Entamoeba species in South Africa: Correlations with the host microbiome, parasite burdens, and first description of Entamoeba bangladeshi outside of Asia. The Journal of Infectious Diseases. 2017;216:1592-1600. DOI: 10.1093/infdis/jix535
  25. 25. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter study, GEMS): A prospective, case-control study. The Lancet. 2013;382:209-222. DOI: 10.1016/s0140-6736(13)60844-2
  26. 26. Weedall GD, Hall N. Evolutionary genomics of Entamoeba. Research in Microbiology. 2011;162:637-645. DOI: 10.1016/j.resmic.2011.01.007
  27. 27. Clark CG, Alsmark UC, Tazreiter M, Saito-Nakano Y, Ali V, Marion S, et al. Structure and content of the Entamoeba histolytica genome. Advances in Parasitology. 2007;65:51-190. DOI: 10.1016/s0065-308x(07)65002-7
  28. 28. Willhoeft U, Tannich E. The electrophoretic karyotype of Entamoeba histolytica. Molecular and Biochemical Parasitology. 1999;99:41-53. DOI: 10.1016/s0166-6851(98)00178-9
  29. 29. Riveron AM, Lopez-Canovas L, Baez-Camargo M, Flores E, Perez-Perez G, Luna-Arias JP, et al. Circular and linear DNA molecules in the Entamoeba histolytica complex molecular karyotype. European Biophysics Journal. 2000;29:48-56. DOI: 10.1007/s002490050250
  30. 30. Lorenzi HA, Puiu D, Miller JR, Brinkac LM, Amedeo P, Hall N, et al. New assembly, reannotation and analysis of the Entamoeba histolytica genome reveal new genomic features and protein content information. PLoS Neglected Tropical Diseases. 2010;4:e716. DOI: 10.1371/journal.pntd.0000716
  31. 31. Bhattacharya S, Som I, Bhattacharya A. The ribosomal DNA plasmids of entamoeba. Parasitology Today. 1998;14:181-185. DOI: 10.1016/s0169-4758(98)01222-8
  32. 32. Clark CG, Ali IK, Zaki M, Loftus BJ, Hall N. Unique organisation of tRNA genes in Entamoeba histolytica. Molecular and Biochemical Parasitology. 2006;146:24-29. DOI: 10.1016/j.molbiopara.2005.10.013
  33. 33. Ali IK, Zaki M, Clark CG. Use of PCR amplification of tRNA gene-linked short tandem repeats for genotyping Entamoeba histolytica. Journal of Clinical Microbiology. 2005;43:5842-5847. DOI: 10.1128/jcm.43.12.5842-5847.2005
  34. 34. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Laboratory diagnostic techniques for Entamoeba species. Clinical Microbiology Reviews. 2007;20:511-532. DOI: 10.1128/CMR.00004-07
  35. 35. Sargeaunt PG, Jackson TF, Wiffen S, Bhojnani R, Williams JE, Felmingham D, et al. The reliability of Entamoeba histolytica zymodemes in clinical laboratory diagnosis. Archivos de Investigación Médica(Mex). 1987;18:69-75
  36. 36. Blanc D, Sargeaunt P. Entamoeba histolytica zymodemes: Exhibition of γ and δ bands only of glucose phosphate isomerase and phosphoglucomutase may be influenced by starch content in the medium. Experimental Parasitology. 1991;72:87-90
  37. 37. Jackson T, Suparsad S. Zymodeme stability of Entamoeba histolytica and E. dispar. Archives of Medical Research. 1997;28:304-305
  38. 38. Clark CG, Zaki M, Ali IKM. Genetic diversity in Entamoeba histolytica. Journal of Biosciences. 2002;27:603-607. DOI: 10.1007/BF02704854
  39. 39. Chatterjee S, Raval IH. Pathogenic microbial genetic diversity with reference to health. In: Das S, Dash HR, editors. Microbial Diversity in the Genomic Era. 1st ed. Bhavnagar: Academic Press; 2019. pp. 559-577. DOI: 10.1016/C2017-0-01759-7
  40. 40. Samie A, Obi CL, Bessong PO, Houpt E, Stroup S, Njayou M, et al. Entamoeba histolytica: Genetic diversity of African strains based on the polymorphism of the serine-rich protein gene. Experimental Parasitology. 2008;118:354-361. DOI: 10.1016/j.exppara.2007.09.008
  41. 41. Paul J, Srivastava S, Bhattacharya S. Molecular methods for diagnosis of Entamoeba histolytica in a clinical setting: An overview. Experimental Parasitology. 2007;116:35-43. DOI: 10.1016/j.exppara.2006.11.005
  42. 42. Manochitra K, Parija SC. In-silico prediction and modeling of the Entamoeba histolytica proteins: Serine-rich Entamoeba histolytica protein and 29 kDa cysteine-rich protease. PeerJ. 2017;5:e3160. DOI: 10.7717/peerj.3160
  43. 43. Teixeira JE, Huston CD. Participation of the serine-rich Entamoeba histolytica protein in amebic phagocytosis of apoptotic host cells. Infection and Immunity. 2008;76:959-966. DOI: 10.1128/iai.01455-07
  44. 44. ElBakri A, Samie A, Ezzedine S, Odeh R. Genetic variability of the serine-rich Entamoeba histolytica protein gene in clinical isolates from the United Arab Emirates. Tropical Biomedicine. 2014;31:370-377
  45. 45. Stanley SL Jr, Becker A, Kunz-Jenkins C, Foster L, Li E. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:4976-4980. DOI: 10.1073/pnas.87.13.4976
  46. 46. Haghighi A, Kobayashi S, Takeuchi T, Thammapalerd N, Nozaki T. Geographic diversity among genotypes of Entamoeba histolytica field isolates. Journal of Clinical Microbiology. 2003;41:3748-3756. DOI: 10.1128/jcm.41.8.3748-3756.2003
  47. 47. Weedall GD, Clark CG, Koldkjaer P, Kay S, Bruchhaus I, Tannich E, et al. Genomic diversity of the human intestinal parasite Entamoeba histolytica. Genome Biology. 2012;13:R38. DOI: 10.1186/gb-2012-13-5-r38
  48. 48. Escueta-de Cadiz A, Kobayashi S, Takeuchi T, Tachibana H, Nozaki T. Identification of an avirulent Entamoeba histolytica strain with unique tRNA-linked short tandem repeat markers. Parasitology International. 2010;59:75-81. DOI: 10.1016/j.parint.2009.10.010
  49. 49. Zaki M, Meelu P, Sun W, Clark CG. Simultaneous differentiation and typing of Entamoeba histolytica and Entamoeba dispar. Journal of Clinical Microbiology. 2002;40:1271-1276. DOI: 10.1128/jcm.40.4.1271-1276.2002
  50. 50. Zaki M, Reddy SG, Jackson TF, Ravdin JI, Clark CG. Genotyping of Entamoeba species in South Africa: Diversity, stability, and transmission patterns within families. The Journal of Infectious Diseases. 2003;187:1860-1869. DOI: 10.1086/375349
  51. 51. de la Vega H, Specht CA, Semino CE, Robbins PW, Eichinger D, Caplivski D, et al. Cloning and expression of chitinases of Entamoebae. Molecular and Biochemical Parasitology. 1997;85:139-147. DOI: 10.1016/s0166-6851(96)02817-4
  52. 52. Cruz-Reyes J, ur-Rehman T, Spice WM, Ackers JP. A novel transcribed repeat element from Entamoeba histolytica. Gene. 1995;166(1):183-184. DOI: 10.1016/0378-1119(95)00549-x
  53. 53. Van Dellen K, Field J, Wang Z, Loftus B. Samuelson J.LINEs and SINE-like elements of the protist Entamoeba histolytica. Gene. 2002;297:229-239. DOI: 10.1016/s0378-1119(02)00917-4
  54. 54. Sharma R, Bagchi A, Bhattacharya A, Bhattacharya S. Characterization of a retrotransposon-like element from Entamoeba histolytica. Molecular and Biochemical Parasitology. 2001;116:45-53. DOI: 10.1016/s0166-6851(01)00300-0
  55. 55. Bhattacharya S, Bakre A, Bhattacharya A. Mobile genetic elements in protozoan parasites. Journal of Genetics. 2002;81:73-86. DOI: 10.1007/bf02715903
  56. 56. Casa AM, Nagel A, Wessler SR. MITE display. Methods in Molecular Biology. 2004;260:175-188. DOI: 10.1385/1-59259-755-6:175
  57. 57. Casa AM, Brouwer C, Nagel A, Wang L, Zhang Q , Kresovich S, et al. The MITE family heartbreaker (Hbr): Molecular markers in maize. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:10083-10089. DOI: 10.1073/pnas.97.18.10083
  58. 58. Flavell AJ, Knox MR, Pearce SR, Ellis TH. Retrotransposon-based insertion polymorphisms (RBIP) for high throughput marker analysis. The Plant Journal. 1998;16:643-650. DOI: 10.1046/j.1365-313x.1998.00334.x
  59. 59. Sharma VM, Chopra R, Ghosh I, Ganesan K. Quantitative target display: A method to screen yeast mutants conferring quantitative phenotypes by 'mutant DNA fingerprints'. Nucleic Acids Research. 2001;29:E86-E86. DOI: 10.1093/nar/29.17.e86
  60. 60. Srivastava S, Bhattacharya S, Paul J. Species- and strain-specific probes derived from repetitive DNA for distinguishing Entamoeba histolytica and Entamoeba dispar. Experimental Parasitology. 2005;110:303-308. DOI: 10.1016/j.exppara.2005.02.020
  61. 61. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research. 1991;19:6823-6831. DOI: 10.1093/nar/19.24.6823
  62. 62. Pounder JI, Williams S, Hansen D, Healy M, Reece K, Woods GL. Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. Journal of Clinical Microbiology. 2005;43:2141-2147. DOI: 10.1128/jcm.43.5.2141-2147.2005
  63. 63. Gahlawat G, Srivastava A. Microbial Production of PHB and its Copolymers (PhD Thesis). Delhi, India: Indian Institute of Technology; 2014
  64. 64. Bhattacharya D, Haque R, Singh U. Coding and noncoding genomic regions of Entamoeba histolytica have significantly different rates of sequence polymorphisms: Implications for epidemiological studies. Journal of Clinical Microbiology. 2005;43:4815-4819. DOI: 10.1128/jcm.43.9.4815-4819.2005
  65. 65. Wang Z, Vora GJ, Stenger DA. Detection and genotyping of Entamoeba histolytica, Entamoeba dispar, Giardia lamblia, and Cryptosporidium parvum by oligonucleotide microarray. Journal of Clinical Microbiology. 2004;42:3262-3271. DOI: 10.1128/jcm.42.7.3262-3271.2004
  66. 66. MacFarlane R, Bhattacharya D, Singh U. Genomic DNA microarrays for Entamoeba histolytica: Applications for use in expression profiling and strain genotyping. Experimental Parasitology. 2005;110:196-202. DOI: 10.1016/j.exppara.2005.03.006
  67. 67. Davhana NC, Mbati PA, Samie A, editors. Molecular characterization of Entamoeba histolytica tRNA genes. In: Eukaryome Impact on Human Intestine Homeostasis and Mucosal Immunology. Cham: Springer International Publishing; 2020
  68. 68. Das K, Chowdhury P, Nozaki T, Ganguly S. Genetic characterization of Entamoeba histolytica reveals a significant association of parasite genotype with disease outcome. Journal of Advances in Biotechnology. 2016;6:798-806. DOI: 10.24297/jbt.v6i1.4815
  69. 69. Mahmood SAF. Epidemiological, molecular and immunological studies of Entamoeba histolytica among Erbil population with roles of cysteine protease and phospholipase B in the pathogenicity [thesis]. Erbil Province of Iraq: Hawler Medical University; 2020
  70. 70. Olivia Valenzuela PM, Ramos F, Cardoza JI, García G, Valadez A, Liliana Rojas AG, et al. Short Report: Two different chitinase genotypes in a patient with an amebic liver abscess: A case. Report American Journal of Tropical Medicine and Hygiene. 2009;80:51-54
  71. 71. Thibeaux R, Weber C, Hon CC, Dillies MA, Avé P, Coppée JY, et al. Identification of the virulence landscape essential for Entamoeba histolytica invasion of the human colon. PLoS Pathogens. 2013;9:e1003824. DOI: 10.1371/journal.ppat.1003824

Written By

Shler Akram Faqe Mahmood

Submitted: 03 July 2022 Reviewed: 28 July 2022 Published: 19 January 2023